Prognostic and predictive role of JWA and XRCC 1 expression in gastric cancer

Department of Molecular Cell Biology and Toxicology, Jiangsu Key Lab of Cancer Biomarkers, Prevention & Treatment, Cancer Center; School of Public Health, Nanjing Medical University, 140 Hanzhong Road, Nanjing 210029, People’s Republic of China; Department of Pathology, Nantong Cancer Hospital, Nantong 226361, Jiangsu Province, People’s Republic of China; Department of Oncology, Yixing Hospital, Yixing 214200, Jiangsu Province, People's Republic of China; Laboratory of Biological Cancer Therapy, Xuzhou Medical College, Xuzhou 221002, Jiangsu Province, People's Republic of China; Department of Dermatology and Skin Science, Jack Bell Research Centre, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia V6H 3Z6, Canada; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim 7491, Norway and Cancer Clinic, Levanger Hospital, Nord-Trøndelag Health Trust, Levanger 7600, Norway

[1]  D. Sargent,et al.  Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. , 2010, JAMA.

[2]  Yikai Zhou,et al.  Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms. , 2010, Toxicology letters.

[3]  J. Pignon,et al.  Immunogenic death of colon cancer cells treated with oxaliplatin , 2010, Oncogene.

[4]  C. Bokemeyer,et al.  Pharmacogenetic analyses of a phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil and leucovorin plus either oxaliplatin or cisplatin: a study of the arbeitsgemeinschaft internistische onkologie. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Johnston,et al.  Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy , 2010, Oncogene.

[6]  K. Pan,et al.  Association between genetic polymorphisms of DNA base excision repair genes and evolution of precancerous gastric lesions in a Chinese population. , 2009, Carcinogenesis.

[7]  Gang Li,et al.  JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks , 2009, Nucleic acids research.

[8]  D. Rimm,et al.  A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Keith W. Caldecott,et al.  Single-strand break repair and genetic disease , 2008, Nature Reviews Genetics.

[10]  Yusuke Nakamura,et al.  Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer , 2008, Nature Genetics.

[11]  C. Bokemeyer,et al.  Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Carsten Denkert,et al.  Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. , 2008, The Lancet. Oncology.

[13]  L. Mullenders,et al.  Sealing of chromosomal DNA nicks during nucleotide excision repair requires XRCC1 and DNA ligase III alpha in a cell-cycle-specific manner. , 2007, Molecular cell.

[14]  T. Helleday,et al.  DNA double-strand break repair: from mechanistic understanding to cancer treatment. , 2007, DNA repair.

[15]  Hai-rong Chen,et al.  JWA as a functional molecule to regulate cancer cells migration via MAPK cascades and F-actin cytoskeleton. , 2007, Cellular signalling.

[16]  Q. Wei,et al.  Identification and Functional Characterization of JWA Polymorphisms and their Association with Risk of Gastric Cancer and Esophageal Squamous Cell Carcinoma in a Chinese Population , 2007, Journal of toxicology and environmental health. Part A.

[17]  K. Caldecott.  Mammalian single-strand break repair: mechanisms and links with chromatin. , 2007, DNA repair.

[18]  V. Bohr,et al.  The mechanics of base excision repair, and its relationship to aging and disease. , 2007, DNA repair.

[19]  A. Gazdar.  DNA repair and survival in lung cancer--the two faces of Janus. , 2007, The New England journal of medicine.

[20]  Zhong Zheng,et al.  DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. , 2007, The New England journal of medicine.

[21]  M. Dolan,et al.  Molecular mechanisms of resistance and toxicity associated with platinating agents. , 2007, Cancer treatment reviews.

[22]  J. Ajani,et al.  Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  J. Ajani,et al.  Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  C. Zou,et al.  JWA, a novel signaling molecule, involved in the induction of differentiation of human myeloid leukemia cells. , 2006, Biochemical and biophysical research communications.

[25]  A. Kiltie,et al.  APE1 and XRCC1 Protein Expression Levels Predict Cancer-Specific Survival Following Radical Radiotherapy in Bladder Cancer , 2005, Clinical Cancer Research.

[26]  J. Klaunig,et al.  The role of oxidative stress in carcinogenesis. , 2004, Annual review of pharmacology and toxicology.

[27]  R. Tebbs,et al.  Rescue of Xrcc1 knockout mouse embryo lethality by transgene-complementation. , 2003, DNA repair.

[28]  Mitsuko Masutani,et al.  A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage. , 2003, Nucleic acids research.

[29]  Tatjana Crnogorac-Jurcevic,et al.  Expression profiling of microdissected pancreatic adenocarcinomas , 2002, Oncogene.

[30]  T. Lumley,et al.  Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.

[31]  J. Hoeijmakers,et al.  Nucleotide excision repair and human syndromes. , 2000, Carcinogenesis.

[32]  Penny A. Johnson,et al.  A Cell Cycle-Specific Requirement for the XRCC1 BRCT II Domain during Mammalian DNA Strand Break Repair , 2000, Molecular and Cellular Biology.

[33]  D. Barnes,et al.  Reconstitution of DNA base excision‐repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. , 1996, The EMBO journal.

[34]  Wang Yang.  DNA Repair by ERCC1 in Non-Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy , 2010 .

[35]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[36]  B. Wickstead,et al.  Role of a BRCT domain in the interaction of DNA ligase III-alpha with the DNA repair protein XRCC1. , 1998, Current biology : CB.